Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Saskatchewan

$25,000.00

Nanoparticle formulation and evaluation of novel synthetic immune stimulating agents

FY 2015-16

Summary
The use of antibiotics in the farm animals has been a common practice to prevent them from infections as well as to increase the their growth quickly for many years. However, the danger of emergence of antibiotic resistance in humans has been linked to the uncontrolled use of antibiotics in farm animals and hence necessary measures have been implemented in most developed and developing countries around the world. Boosting the immune system of farm animals to prevent infection is an alternate approach to prevent or limit the use of antibiotics. Alberta Research Chemicals (ARCI) is currently developing novel immunestimulating agents to use them as veterinary vaccines in general to improve their innate immunity. ARCI has synthesized several ligands for various immune receptors such as Toll like receptors, Nucleotide Oligomerization Domain (NOD) like receptors and looking for formulating them into biodegradable nanoparticles for their effective delivery to animals. The current research proposal is to formulate ARCI products into PLGA nanoparticles and study their immune stimulation efficacy using the applicants established in vitro cell culture studies. The proposed research will provide a strong intellectual property to ARCI and help establishing a long term collaboration with the applicant. The outcome of this project would eventually contribute to economic and social benefit to Canada.
Program
Engage Grants Program
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
490569-2015
Name nom
Haddadi, Azita
Department département
Pharmacy and Nutrition, College of
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
1
Nb partie
1
Application title
Nanoparticle formulation and evaluation of novel synthetic immune stimulating agents
Keyword
NSERC
Application summary
The use of antibiotics in the farm animals has been a common practice to prevent them from infections as well as to increase the their growth quickly for many years. However, the danger of emergence of antibiotic resistance in humans has been linked to the uncontrolled use of antibiotics in farm animals and hence necessary measures have been implemented in most developed and developing countries around the world. Boosting the immune system of farm animals to prevent infection is an alternate approach to prevent or limit the use of antibiotics. Alberta Research Chemicals (ARCI) is currently developing novel immunestimulating agents to use them as veterinary vaccines in general to improve their innate immunity. ARCI has synthesized several ligands for various immune receptors such as Toll like receptors, Nucleotide Oligomerization Domain (NOD) like receptors and looking for formulating them into biodegradable nanoparticles for their effective delivery to animals. The current research proposal is to formulate ARCI products into PLGA nanoparticles and study their immune stimulation efficacy using the applicants established in vitro cell culture studies. The proposed research will provide a strong intellectual property to ARCI and help establishing a long term collaboration with the applicant. The outcome of this project would eventually contribute to economic and social benefit to Canada.